Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
35,033
archived clinical trials in
Lung Cancer

Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Jameson Memorial Hospital - North Campus
mi
from
New Castle, PA
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Jameson Memorial Hospital - North Campus
mi
from
New Castle, PA
Click here to add this to my saved trials
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Fox Chase Cancer Center - Philadelphia
mi
from
Philadelphia, PA
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Fox Chase Cancer Center - Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Allegheny Cancer Center at Allegheny General Hospital
mi
from
Pittsburgh, PA
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Allegheny Cancer Center at Allegheny General Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital
mi
from
Pittsburgh, PA
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Hillman Cancer Center at University of Pittsburgh Cancer Institute
mi
from
Pittsburgh, PA
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Hillman Cancer Center at University of Pittsburgh Cancer Institute
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Veterans Affairs Medical Center - Pittsburgh
mi
from
Pittsburgh, PA
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Veterans Affairs Medical Center - Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Lankenau Cancer Center at Lankenau Hospital
mi
from
Wynnewood, PA
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Lankenau Cancer Center at Lankenau Hospital
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Rhode Island Hospital Comprehensive Cancer Center
mi
from
Providence, RI
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Rhode Island Hospital Comprehensive Cancer Center
mi
from
Providence, RI
Click here to add this to my saved trials
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Miriam Hospital
mi
from
Providence, RI
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
AnMedical Health Cancer Center
mi
from
Anderson, SC
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
AnMedical Health Cancer Center
mi
from
Anderson, SC
Click here to add this to my saved trials
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Hollings Cancer Center at Medical University of South Carolina
mi
from
Charleston, SC
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Hollings Cancer Center at Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
CCOP - Upstate Carolina
mi
from
Spartanburg, SC
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
CCOP - Upstate Carolina
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
mi
from
Spartanburg, SC
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
U.T. Cancer Institute at University of Tennessee Medical Center
mi
from
Knoxville, TN
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
U.T. Cancer Institute at University of Tennessee Medical Center
mi
from
Knoxville, TN
Click here to add this to my saved trials
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
LDS Hospital
mi
from
Salt Lake City, UT
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
LDS Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
University of Virginia Cancer Center
mi
from
Charlottesville, VA
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
University of Virginia Cancer Center
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Swedish Cancer Institute at Swedish Medical Center - First Hill Campus
mi
from
Seattle, WA
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Swedish Cancer Institute at Swedish Medical Center - First Hill Campus
mi
from
Seattle, WA
Click here to add this to my saved trials
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Mary Babb Randolph Cancer Center at West Virginia University Hospitals
mi
from
Morgantown, WV
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Mary Babb Randolph Cancer Center at West Virginia University Hospitals
mi
from
Morgantown, WV
Click here to add this to my saved trials
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Green Bay Oncology, Limited at St. Vincent Hospital
mi
from
Green Bay, WI
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Green Bay Oncology, Limited at St. Vincent Hospital
mi
from
Green Bay, WI
Click here to add this to my saved trials
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Green Bay Oncology, Limited at St. Mary's Hospital
mi
from
Green Bay, WI
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Green Bay Oncology, Limited at St. Mary's Hospital
mi
from
Green Bay, WI
Click here to add this to my saved trials
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
St. Mary's Hospital Medical Center - Green Bay
mi
from
Green Bay, WI
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
St. Mary's Hospital Medical Center - Green Bay
mi
from
Green Bay, WI
Click here to add this to my saved trials
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
St. Vincent Hospital Regional Cancer Center
mi
from
Green Bay, WI
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
St. Vincent Hospital Regional Cancer Center
mi
from
Green Bay, WI
Click here to add this to my saved trials
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Toronto General Hospital
mi
from
Toronto,
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Toronto General Hospital
mi
from
Toronto,
Click here to add this to my saved trials
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Mayo Clinic Scottsdale
mi
from
Scottsdale, AZ
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Mayo Clinic Scottsdale
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Aurora Presbyterian Hospital
mi
from
Aurora, CO
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Aurora Presbyterian Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Boulder Community Hospital
mi
from
Boulder, CO
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Boulder Community Hospital
mi
from
Boulder, CO
Click here to add this to my saved trials
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Penrose Cancer Center at Penrose Hospital
mi
from
Colorado Springs, CO
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Penrose Cancer Center at Penrose Hospital
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
St. Anthony Central Hospital
mi
from
Denver, CO
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
St. Anthony Central Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Porter Adventist Hospital
mi
from
Denver, CO
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Porter Adventist Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Presbyterian - St. Luke's Medical Center
mi
from
Denver, CO
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Presbyterian - St. Luke's Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
St. Joseph Hospital
mi
from
Denver, CO
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
St. Joseph Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Rose Medical Center
mi
from
Denver, CO
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Rose Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
CCOP - Colorado Cancer Research Program, Inc.
mi
from
Denver, CO
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
CCOP - Colorado Cancer Research Program, Inc.
mi
from
Denver, CO
Click here to add this to my saved trials
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Swedish Medical Center
mi
from
Englewood, CO
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Swedish Medical Center
mi
from
Englewood, CO
Click here to add this to my saved trials
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
mi
from
Grand Junction, CO
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
mi
from
Grand Junction, CO
Click here to add this to my saved trials
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
North Colorado Medical Center
mi
from
Greeley, CO
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
North Colorado Medical Center
mi
from
Greeley, CO
Click here to add this to my saved trials
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Sky Ridge Medical Center
mi
from
Lone Tree, CO
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Sky Ridge Medical Center
mi
from
Lone Tree, CO
Click here to add this to my saved trials
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Hope Cancer Care Center at Longmont United Hospital
mi
from
Longmont, CO
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Hope Cancer Care Center at Longmont United Hospital
mi
from
Longmont, CO
Click here to add this to my saved trials
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
McKee Medical Center
mi
from
Loveland, CO
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
McKee Medical Center
mi
from
Loveland, CO
Click here to add this to my saved trials
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
St. Mary - Corwin Regional Medical Center
mi
from
Pueblo, CO
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
St. Mary - Corwin Regional Medical Center
mi
from
Pueblo, CO
Click here to add this to my saved trials
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
North Suburban Medical Center
mi
from
Thornton, CO
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
North Suburban Medical Center
mi
from
Thornton, CO
Click here to add this to my saved trials
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Exempla Lutheran Medical Center
mi
from
Wheat Ridge, CO
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Exempla Lutheran Medical Center
mi
from
Wheat Ridge, CO
Click here to add this to my saved trials
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Rush-Copley Cancer Care Center
mi
from
Aurora, IL
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Rush-Copley Cancer Care Center
mi
from
Aurora, IL
Click here to add this to my saved trials
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Illinois CancerCare-Bloomington
mi
from
Bloomington, IL
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Illinois CancerCare-Bloomington
mi
from
Bloomington, IL
Click here to add this to my saved trials
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
St. Joseph Medical Center
mi
from
Bloomington, IL
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
St. Joseph Medical Center
mi
from
Bloomington, IL
Click here to add this to my saved trials
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Graham Hospital
mi
from
Canton, IL
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Graham Hospital
mi
from
Canton, IL
Click here to add this to my saved trials
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Illinois CancerCare - Canton
mi
from
Canton, IL
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Illinois CancerCare - Canton
mi
from
Canton, IL
Click here to add this to my saved trials
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/6/2015
Illinois CancerCare - Carthage
mi
from
Carthage, IL
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/6/2015
Illinois CancerCare - Carthage
mi
from
Carthage, IL
Click here to add this to my saved trials